We are attending ASVS 2025 in Singapore

31 July 2025

Founder of Venous Stent, Professor Dr. Cees Wittens, to Attend ASVS 2025 in Singapore

Venous Stent B.V., a Netherlands-based medtech company pioneering next-generation venous stent technology, today announced that its Founder, Professor Dr. Cees Wittens, will attend the upcoming Asian Society for Vascular Surgery (ASVS) 2025 Congress in Singapore.

ASVS is one of the most prominent vascular surgery conferences in the Asia-Pacific region, gathering leading clinicians, researchers, and innovators to discuss the latest advances in vascular treatment. Professor Dr. Wittens, a world-renowned expert in venous surgery and former Professor of Venous Surgery at Maastricht University, will engage with international peers and highlight the company’s progress in developing an advanced iliac venous stent platform tailored to address the complex challenges of deep venous disease.

“ASVS provides a unique opportunity to connect with global leaders in vascular care and to share insights on innovations that have the potential to transform treatment,” said Professor Dr. Cees Wittens, Founder of Venous Stent B.V. “We are committed to delivering a device that improves outcomes for patients worldwide, and collaboration with the clinical community is central to achieving that goal.”

Venous Stent B.V. is currently advancing toward its first-in-human study, with a strong focus on clinical collaboration, regulatory progress, and the development of strategic partnerships.